Must credit the San Francisco Chronicle
By BERNADETTE TANSEY
San Francisco Chronicle
In just two decades, Gilead Sciences Inc., the San Francisco Bay Area's second-largest biotechnology company, has established itself as the nation's dominant seller of HIV drugs, with such products accounting for two-thirds of its $3 billion in revenue in 2006.